News on diagnostic systems for drugs of abuse and toxicology.
As the circle of doctors ordering drug testing expands, labs find themselves more involved in advisory and interpretive roles that go beyond running assays.
The ongoing opioid epidemic has heightened demand among physicians for more frequent and more rapid drug testing.
A deep analysis of data from drug tests performed at Quest over the past six years has helped the company identify which drug tests are needed by clinicians.
Molecular Testing Labs allegedly made payments to labs in exchange for Medicare and Tricare referrals between August 2014 and July 2015.
The Tulsa, Oklahoma-based lab, which received its CLIA license in August, will run samples reimbursed by Medicare and state Medicaid agencies only.